Share on LinkedInShare on LinkedIn

ARTICLE · 29 NOVEMBER 2020

Using Patents To Best Protect Antibody-based Drugs In Russia

Gowling WLG
Gowling WLG
Contributor
Gowling WLG

Gowling WLG

The firm The firm’s lawyers speak English, French, Russian and Ukrainian. The firm’s client base...

View firm profile
Explore more from Gowling WLG

Antibody-based drugs are among the widest selling in the world. They are being used to treat a expanding range of conditions and their significance and value in treating cancer continues

CanadaIntellectual Property

This article was originally publised by IAM Media

Antibody-based drugs are among the widest selling in the world. They are being used to treat a expanding range of conditions and their significance and value in treating cancer continues to grow. Accordingly, this makes them an indispensable component of the pharmaceutical industry and it also means that their protection through invention patents is absolutely essential. Some aspects of the process for antibody-related patent applications in Russia are examined below as a guide for properly drafting claims and obtaining patents with reasonable claims coverage.

Overview

Antibodies are proteins that the immune system uses to neutralise pathogens. Monoclonal antibodies are used in cancer treatments – these are based on finding specific differences between cancerous cells and normal cells, as these antibodies can recognise and bind to specific pathogens, called antigens. Antibodies can be combined with cytotoxic

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from